Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
ADPT Insider Trading: Insider Buys and Sells · https://wallstpal.com/stock/adpt/insider-trading/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Insider tradingForm 4

Adaptive Biotechnologies Corp (ADPT) Insider Trading

43 open-market trades reported since Jun 15, 2026: 0 purchases worth $0 and 43 sales worth $59.5M.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Julie RubinsteinCOO0$018$5.56MOct 26, 2026
Susan BobulskyChief Commercial Officer, MRD0$08$655KOct 8, 2026
Francis LoChief People Officer0$05$8.54MOct 5, 2026
Katey Einterz OwenDirector0$01$250KAug 28, 2026
Robert HershbergDirector0$01$748KAug 20, 2026
Chad M. RobinsCEO0$02$14.9MAug 19, 2026
Peter M. NeupertDirector0$01$3.14MAug 19, 2026
Harlan S. RobinsChief Scientific Officer0$04$21.1MJul 23, 2026
Sharon BenzenoChief Commercial Ofc Imm Med0$02$3.50MJun 30, 2026
Michelle Renee GriffinDirector0$01$1.05MJun 29, 2026

All trades

ADPT insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Oct 26Oct 26Julie RubinsteinCOOCOO▼ SELL10b5-111,88126.04$309K−3.0%Form 4 ↗
Oct 26Oct 23Julie RubinsteinCOOCOO▼ SELL10b5-111,88124.98$297K−3.0%Form 4 ↗
Oct 26Oct 22Julie RubinsteinCOOCOO▼ SELL10b5-111,88124.51$291K−3.0%Form 4 ↗
Oct 21Oct 21Julie RubinsteinCOOCOO▼ SELL10b5-111,88125.41$302K−3.0%Form 4 ↗
Oct 21Oct 20Julie RubinsteinCOOCOO▼ SELL10b5-111,88124.53$291K−3.0%Form 4 ↗
Oct 21Oct 19Julie RubinsteinCOOCOO▼ SELL10b5-111,88124.05$286K−3.0%Form 4 ↗
Oct 16Oct 14Julie RubinsteinCOOCOO▼ SELL10b5-111,88125.68$305K−3.0%Form 4 ↗
Oct 16Oct 15Julie RubinsteinCOOCOO▼ SELL10b5-111,88125.61$304K−3.0%Form 4 ↗
Oct 16Oct 16Julie RubinsteinCOOCOO▼ SELL10b5-111,88124.24$288K−3.0%Form 4 ↗
Oct 13Oct 9Julie RubinsteinCOOCOO▼ SELL10b5-111,88126.41$314K−3.0%Form 4 ↗
Oct 13Oct 12Julie RubinsteinCOOCOO▼ SELL10b5-111,88125.51$303K−3.0%Form 4 ↗
Oct 13Oct 13Julie RubinsteinCOOCOO▼ SELL10b5-111,88125.50$303K−3.0%Form 4 ↗
Oct 8Oct 6Julie RubinsteinCOOCOO▼ SELL10b5-111,88127.75$330K−3.0%Form 4 ↗
Oct 8Oct 7Julie RubinsteinCOOCOO▼ SELL10b5-111,88126.40$314K−3.0%Form 4 ↗
Oct 8Oct 8Julie RubinsteinCOOCOO▼ SELL10b5-111,88125.66$305K−3.0%Form 4 ↗
Oct 8Oct 6Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-16,44430.00$193K−1.6%Form 4 ↗
Oct 5Oct 1Francis LoChief People OfficerChief People Officer▼ SELL10b5-126,79228.28$758K−11%Form 4 ↗
Oct 5Oct 5Julie RubinsteinCOOCOO▼ SELL10b5-111,88129.19$347K−3.0%Form 4 ↗
Oct 5Oct 2Julie RubinsteinCOOCOO▼ SELL10b5-111,88128.13$334K−3.0%Form 4 ↗
Oct 5Oct 1Julie RubinsteinCOOCOO▼ SELL10b5-111,88128.05$333K−3.0%Form 4 ↗
Sep 18Sep 16Francis LoChief People OfficerChief People Officer▼ SELL10b5-1115,40628.06$3.24M−34%Form 4 ↗
Sep 17Sep 15Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-11,19527.00$32K−0.3%Form 4 ↗
Aug 28Aug 26Katey Einterz OwenDirectorDirector▼ SELL9,61526.00$250K−11%Form 4 ↗
Aug 20Aug 18Robert HershbergDirectorDirector▼ SELL30,66424.40$748K−40%Form 4 ↗
Aug 19Aug 17Chad M. RobinsCEOCEO▼ SELL321,32425.08$8.06M−13%Form 4 ↗
Aug 19Aug 18Chad M. RobinsCEOCEO▼ SELL278,67624.48$6.82M−11%Form 4 ↗
Aug 19Aug 17Peter M. NeupertDirectorDirector▼ SELL124,69025.15$3.14M−49%Form 4 ↗
Aug 12Aug 10Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-13,00025.00$75K−0.8%Form 4 ↗
Aug 3Jul 30Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-11,29924.00$31K−0.3%Form 4 ↗
Jul 23Jul 21Harlan S. RobinsChief Scientific OfficerChief Scientific Officer▼ SELL10b5-1492,40021.89$10.8M−38%Form 4 ↗
Jul 20Jul 16Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-15,00023.00$115K−1.2%Form 4 ↗
Jul 17Jul 15Francis LoChief People OfficerChief People Officer▼ SELL10b5-1105,76222.59$2.39M−31%Form 4 ↗
Jul 7Jul 2Harlan S. RobinsChief Scientific OfficerChief Scientific Officer▼ SELL10b5-1386,24022.01$8.50M−28%Form 4 ↗
Jul 6Jul 1Francis LoChief People OfficerChief People Officer▼ SELL10b5-151,00422.45$1.14M−18%Form 4 ↗
Jul 6Jul 2Francis LoChief People OfficerChief People Officer▼ SELL10b5-144,83822.59$1.01M−16%Form 4 ↗
Jul 6Jul 1Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-148722.00$11K−0.1%Form 4 ↗
Jun 30Jun 29Sharon BenzenoChief Commercial Ofc Imm MedChief Commercial Ofc Imm Med▼ SELL10b5-1154,76821.14$3.27M−41%Form 4 ↗
Jun 30Jun 26Sharon BenzenoChief Commercial Ofc Imm MedChief Commercial Ofc Imm Med▼ SELL10b5-111,03421.00$232K−3.9%Form 4 ↗
Jun 29Jun 25Michelle Renee GriffinDirectorDirector▼ SELL10b5-152,08420.18$1.05M−77%Form 4 ↗
Jun 29Jun 25Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-15,00020.50$103K−1.2%Form 4 ↗
Jun 17Jun 15Harlan S. RobinsChief Scientific OfficerChief Scientific Officer▼ SELL10b5-1100,00017.37$1.74M−6.6%Form 4 ↗
Jun 17Jun 16Harlan S. RobinsChief Scientific OfficerChief Scientific Officer▼ SELL10b5-16,16018.01$111K−0.4%Form 4 ↗
Jun 15Jun 11Susan BobulskyChief Commercial Officer, MRDChief Commercial Officer, MRD▼ SELL10b5-15,00019.00$95K−1.2%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings